2015
CALGB 70604 (Alliance): A randomized phase III study of standard dosing vs. longer interval dosing of zoledronic acid in metastatic cancer.
Himelstein A, Qin R, Novotny P, Seisler D, Khatcheressian J, Roberts J, Grubbs S, O'Connor T, Weckstein D, Loprinzi C, Shapiro C. CALGB 70604 (Alliance): A randomized phase III study of standard dosing vs. longer interval dosing of zoledronic acid in metastatic cancer. Journal Of Clinical Oncology 2015, 33: 9501-9501. DOI: 10.1200/jco.2015.33.15_suppl.9501.Peer-Reviewed Original Research
2010
Do African American Men Have Lower Survival From Prostate Cancer Compared With White Men? A Meta-analysis
Sridhar G, Masho SW, Adera T, Ramakrishnan V, Roberts JD. Do African American Men Have Lower Survival From Prostate Cancer Compared With White Men? A Meta-analysis. American Journal Of Men's Health 2010, 4: 189-206. PMID: 20483872, DOI: 10.1177/1557988309353934.Peer-Reviewed Original ResearchConceptsProstate cancer-specific survivalCancer-specific survivalProstate cancerAfrican American menWhite menCancer-related mortalityAmerican menUnadjusted studiesCause mortalityMeta-AnalysisSystematic reviewCancerSurvivalRacial differencesMenSignificant differencesMortalityLower survivalDifferences